Results 231 to 240 of about 26,165 (305)

Neuroinflammation and RAMP1: the Role of the Peripheral and Central Nervous System in Tumor Progression. [PDF]

Cell Biochem Biophys
Cavalcante PDM, da Silva JLD, Oliveira LRS, da Silva RB, Costa Lima JA, Souza GB, Silva Santos DRD, de Abrantes JVN, de Farias ML, Oliveira SAA, da Silva JPE, Calaça Farias RO, de Almeida LPC, de Melo SBS, de Araújo ST, de França-Júnior RR, Xavier JE, Carvalho Fraga CA.   +17 more
europepmc   +1 more source

tVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
Experimental design and key findings. Four groups (Control+Sham, Control+tVNS, LPS+Sham, LPS+tVNS; n = 7 each) underwent serum ELISA, brain Western blot, and behavioral testing. tVNS altered serum Haptoglobin, IL‐6, CGRP1, and VE‐Cadherin levels, reversed LPS‐induced increases in brain IL‐1β, HMGB1, Haptoglobin, PAR‐2, and CGRP, and alleviated LPS ...
Kerem Atalar, Ece Alim, Aysen Calikusu, Elif Gulcicek Abbasoglu Topa, Hale Gok Dagidir, Meltem Bahcelioglu, Neslihan Bukan, Fusun Erten, Kazım Sahin, Saadet Özen Akarca Dizakar, Hayrunnisa Bolay   +10 more
wiley   +1 more source

Beyond the boundaries of pigmentation and inflammation: understanding the mechanistic basis of melasma-rosacea comorbidity. [PDF]

Front Med (Lausanne)
Li X, Shi H, Feng Y.
europepmc   +1 more source

Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis

European Journal of Neurology, Volume 33, Issue 6, June 2026.
In this prospective cohort study, Erenumab and OnabotulinumtoxinA showed similar reductions in headache frequency at 3 and 6 months. Both improved quality of life, while Erenumab achieved greater reductions in migraine‐related disability (MIDAS). These findings support individualized treatment selection.
María Garcés‐Pellejero, Marta Torres‐Ferrús, Rut Mas‐de‐les‐Valls, Edoardo Caronna, Alicia Alpuente, Eulalia Giné‐Ciprés, Patricia Pozo‐Rosich   +6 more
wiley   +1 more source

Neurohormonal-Immune Dysregulation in Rosacea: Emerging Perspectives from the Skin-Gut-Brain Axis. [PDF]

Drug Des Devel Ther
Shi L, Li S, Yao X, Zhang Z, Dong Q, Zhang H, Wang X, Bai J, Han H, Fu X, Zheng K, Liang L.   +11 more
europepmc   +1 more source

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 6, Page 1250-1262, June 2026.
Plain Language Summary Most knowledge about migraine preventive medicines comes from clinical trials, but less is known about their real‐world outcomes and side effects. We followed 254 people with migraine who started on commonly used oral migraine preventive drugs and tracked their results over 12 weeks.
Hedda S. Riise, Melanie R. Simpson, Ketil A. Espnes, Erling A. Tronvik, Andreas K. Husøy, Lise R. Øie, Anker Stubberud, Emil Kofoed, Aurora H. Alstad, Hedda H. Hagen, Maren G. Lien, Marie L. Stavseng, Ella R. Sæther, Tore Wergeland   +13 more
wiley   +1 more source

Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. [PDF]

Mol Metab
Briere DA, Qu H, Lansu K, He MM, Moyers JS, Coskun T, Long A, Allen D, O'Farrell L, Bowen B, Pratt E, Tidemann-Miller B, Tham LS, Ibriga H, Alsina-Fernandez J, Mather KJ, Haupt A, Bhattachar SN.   +17 more
europepmc   +1 more source

Evaluation of the effectiveness and safety of anti‐CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO‐CGRP study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 6, Page 1330-1341, June 2026.
Plain Language Summary Recent studies have found an association between migraine and several chronic inflammatory diseases, such as multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis, suggesting that these conditions might share common immune and vascular pathways.
María Clara García‐Castillo, Álvaro Sierra‐Mencía, Edoardo Caronna, Daniel Toledo‐Alfocea, Alex Jaimes, Sarai Urtiaga, Javier Casas‐Limón, Albert Muñoz‐Vendrell, Sonia Santos‐Lasaosa, Valvanuz García Martín, Guillermo Martín Ávila, Marcos Polanco, Maria Dolores Villar‐Martínez, Cristina Trevino‐Peinado, Laura Rubio‐Flores, Antonio Sánchez‐Soblechero, Leonardo Portocarrero Sánchez, Elisa Luque‐Buzo, Alberto Lozano‐Ros, Ana Beatriz Gago‐Veiga, Javier Díaz‐De‐Terán, Andrea Recio García, Javiera Canales Rodríguez, Andrea Gómez García, Marta González Salaices, Sergio Campoy, Ane Mínguez‐Olaondo, Stefania Maniataki, Vicente González‐Quintanilla, Jesús Porta‐Etessam, María‐Luz Cuadrado, Ángel Luis Guerrero Peral, Patricia Pozo‐Rosich, Jaime Rodríguez‐Vico, Mariano Huerta‐Villanueva, Julio Pascual, Peter J. Goadsby, Alicia Gonzalez‐Martinez   +37 more
wiley   +1 more source

The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications. [PDF]

BMC Med
Wu Y, Zhang K, Xia X, Zhang T, Jiang N, Zhang Y, Zheng F, Jiang Y, Xiang X, Miao H, Tang H, Ren S, Li MY.   +12 more
europepmc   +1 more source

Amylin Revisited: A 5-Year Perspective on Its Emerging Role in the Treatment of Diabesity. [PDF]

J Obes Metab Syndr
Chung CW, Kim J.
europepmc   +1 more source